• Saved

February 16, 2021

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862995/

Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.Patients ...

  • February 16, 2021
    Would caution drawing conclusions on this retrospective study as patients who received a double autoSCT may have had inferior survival simply related to biologically worse disease